The “Great Debate” at Immunotherapy Bridge 2020, December 3rd, 2020

The “Great Debate” at Immunotherapy Bridge 2020, December 3rd, 2020

Abstract As part of the 2020 Immunotherapy Bridge virtual congress (December 2nd–3rd, Italy), the Great Debate session featured counterpoint views from leading experts on three clinical questions in immunotherapy today. The first of these was whether antitumoral vaccination is still a treatment opti...

Full description

Bibliographic Details
Main Authors: Paolo A. Ascierto, Joshua Brody, Lisa H. Butterfield, Olivera J. Finn, John Goldberg, Francesco Perrone, Ryan J. Sullivan, Bernard A. Fox, Patrick Hwu, Igor Puzanov
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Journal of Translational Medicine
Subjects:
Immunotherapy
Cancer vaccine
Checkpoint inhibitors
Nivolumab
Pembrolizumab
Overall survival
Online Access:https://doi.org/10.1186/s12967-021-02811-8

Internet

https://doi.org/10.1186/s12967-021-02811-8

Similar Items